Association of overexpression of efflux pump genes with antibiotic resistance in Pseudomonas aeruginosa strains clinically isolated from urinary tract infection patients

Journal of Antibiotics

Volumn 68, Issue 9, 2015, Pages 568-572

  Shigemura, Katsumi ^a,b   Osawa, Kayo ^b,c   Kato, Ayaka ^c   Tokimatsu, Issei ^b   Arakawa, Soichi ^a,b   Shirakawa, Toshiro ^a,c   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

^c KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL PROTEIN; BACTERIAL RNA; CEFOZOPRAN; CEFTAZIDIME; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEXB PROTEIN; MEXC PROTEIN; MEXE PROTEIN; MEXY PROTEIN; PIPERACILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CELL DIVISION; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HOUSEKEEPING GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NODULATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; RNA EXTRACTION; URINARY TRACT INFECTION; BACTERIAL GENE; DRUG EFFECTS; GENE; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSEUDOMONAS INFECTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENES, MDR; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, BACTERIAL; URINARY TRACT INFECTIONS;

EID: 84942768040     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2015.34     Document Type: Article

References (32)

1. Hsueh, P.R.et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J. Infect. 63, 114-123 (2011).
2. Lu, P.L. et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). J. Antimicrob. Agents 40, S37-S43 (2012).
3. Xiao, M. et al. Antimicrobial susceptibility of Pseudomonas aeruginosa in China: A review of two multicentre surveillance programmes, and application of revised CLSI susceptibility breakpoints. Int. J. Antimicrob. Agents 40, 445-449 (2012).
4. Lister, P. D., Wolter, D. J. & Hanson, N. D. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22, 582-610 (2009).
5. Piddock, L. J. Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 4, 629-636 (2006).
6. Poole, K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3, 255-264 (2001).
7. Morita, Y., Tomida, J. & Kawamura, Y. Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7. Microbiology 158, 1071-1083 (2012).
8. Li, X. Z., Nikaido, H. & Poole, K. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39, 1948 (1995).
9. Li, X. Z., Barré, N. & Poole, K. Influence of the MexA-MexB-oprM multidrug efflux system on expression of the MexC-MexD-oprJ and MexE-MexF-oprN multidrug efflux systems in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 46, 885-893 (2000).
10. Poole, K., Krebes, K., McNally, C. & Neshat, S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175, 7363-7372 (1993).
11. Morita, Y. et al. Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-Type Pseudomonas aeruginosa PAO1. J. Antimicrob. Chemother. 51, 991-994 (2013).
12. Poole, K. et al. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-Type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21, 713-724 (1996).
13. Köhler, T. et al. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23, 345-354 (1997).
14. Muller, C., Plisiat, P. & Jeannot, K. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55, 1211-1221 (2011).
15. Sacha, P. et al. Expression of MexAB-OprM efflux pump system and susceptibility to antibiotics of different Pseudomonas aeruginosa clones isolated from patients hospitalized in two intensive care units at University Hospital in Bialystok (northeastern Poland) between January 2002 and December 2009. APMIS 122, 931-940 (2014).
16. Aeschlimann, J. R. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Pharmacotherapy 23, 916-924 (2003).
17. Matsumoto, M. et al. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography. Int. J. Antimicrob. Agents 40, 440-444 (2012).
18. CLSI-Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: M100-S19. Clinical Laboratory Standards Institute. Wayne, PA (2009).
19. Fernández, L. & Hancock, R. E. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol. Rev. 25, 661-681 (2012).
20. Poole, K. Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2, 65 (2011).
21. Tomás, M. et al. Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 54, 2219-2224 (2010).
22. Yasufuku, T. et al. Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli strains clinically isolated from urinary tract infection patients. J. Clin. Microbiol. 49, 189-194 (2011).
23. Ozer, B., Duran, N., Onlen, Y. & Savas, L. Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit. J. Antibiot. (Tokyo) 65, 9-13 (2012).
24. Han, J. H. et al. Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli. J. Infect. Dis. 206, 1597-1603 (2012).
25. Gorgani, N., Ahlbrand, S., Patterson, A. & Pourmand, N. (2009) Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 34, 414-4182009.
26. Sadeghifard, N. et al. Relationship between the presence of the nalC mutation and multidrug resistance in Pseudomonas aeruginosa. Int. J. Microbiol. 2012, 575193 (2012).
27. Kiser, T. H., Obritsch, M. D., Jung, R., MacLaren, R. & Fish, D. N. Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa. Pharmacotherapy 30, 632 (2010).
28. Shigemura, K. et al. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study. Int. J. Antimicrob. Agents 40, 516-520 (2012).
29. Masuda, N. et al. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 2242-2246 (2000).
30. Morgan-Linnell, S. K., Becnel Boyd, L., Steffen, D. & Zechiedrich, L. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob. Agents Chemother. 53, 235-241 (2009).
31. Tam, V. H. et al. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa. Diagn. Microbiol. Infect. Dis. 58, 309-314 (2007).
32. Pasca, M. R. et al. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. Microb. Drug Resist. 18, 23-32 (2012).